切割球囊血管成形术治疗颈动脉支架置入术后严重支架内再狭窄:长期疗效和文献综述。

IF 1.2 Q4 CLINICAL NEUROLOGY
Neurointervention Pub Date : 2024-03-01 Epub Date: 2024-02-08 DOI:10.5469/neuroint.2024.00010
Jeong-Yoon Lee, Min-Surk Kye, Jonguk Kim, Do Yeon Kim, Jun Yup Kim, Sung Hyun Baik, Jihoon Kang, Beom Joon Kim, Hee-Joon Bae, Cheolkyu Jung
{"title":"切割球囊血管成形术治疗颈动脉支架置入术后严重支架内再狭窄:长期疗效和文献综述。","authors":"Jeong-Yoon Lee, Min-Surk Kye, Jonguk Kim, Do Yeon Kim, Jun Yup Kim, Sung Hyun Baik, Jihoon Kang, Beom Joon Kim, Hee-Joon Bae, Cheolkyu Jung","doi":"10.5469/neuroint.2024.00010","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Cutting balloon-percutaneous transluminal angioplasty (CB-PTA) is a feasible treatment option for in-stent restenosis (ISR) after carotid artery stenting (CAS). However, the longterm durability and safety of CB-PTA for ISR after CAS have not been well established.</p><p><strong>Materials and methods: </strong>We retrospectively reviewed medical records of patients with ISR after CAS who had been treated with CB-PTA from 2012 to 2021 in our center. Detailed information of baseline characteristics, periprocedural and long-term outcomes, and follow-up imaging was collected.</p><p><strong>Results: </strong>During 2012-2021, a total of 301 patients underwent CAS. Of which, CB-PTA was performed on 20 lesions exhibiting severe ISR in 18 patients following CAS. No patient had any history of receiving carotid endarterectomy or radiation therapy. These lesions were located at the cervical segment of the internal carotid artery (n=16), proximal external carotid artery (n=1), and distal common carotid artery (n=1). The median time interval between initial CAS and detection of ISR was 390 days (interquartile range 324-666 days). The follow-up period ranged from 9 months to 9 years with a median value of 21 months. Four patients (22.2%) were symptomatic. The average of stenotic degree before and after the procedure was 79.2% and 34.7%, respectively. Out of the 18 patients receiving CB-PTA, 16 (88.9%) did not require additional stenting, and 16 (88.9%) did not experience recurrent ISR during the follow-up period. Two patients who experienced recurrent ISR were successfully treated with CB-PTA and additional stenting. No periprocedural complication was observed in any case.</p><p><strong>Conclusion: </strong>Regarding favorable periprocedural and long-term outcomes in our single-center experience, CB-PTA was a feasible and safe option for the treatment of severe ISR after CAS.</p>","PeriodicalId":19140,"journal":{"name":"Neurointervention","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10910177/pdf/","citationCount":"0","resultStr":"{\"title\":\"Cutting Balloon Angioplasty for Severe In-Stent Restenosis after Carotid Artery Stenting: Long-Term Outcomes and Review of Literature.\",\"authors\":\"Jeong-Yoon Lee, Min-Surk Kye, Jonguk Kim, Do Yeon Kim, Jun Yup Kim, Sung Hyun Baik, Jihoon Kang, Beom Joon Kim, Hee-Joon Bae, Cheolkyu Jung\",\"doi\":\"10.5469/neuroint.2024.00010\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Cutting balloon-percutaneous transluminal angioplasty (CB-PTA) is a feasible treatment option for in-stent restenosis (ISR) after carotid artery stenting (CAS). However, the longterm durability and safety of CB-PTA for ISR after CAS have not been well established.</p><p><strong>Materials and methods: </strong>We retrospectively reviewed medical records of patients with ISR after CAS who had been treated with CB-PTA from 2012 to 2021 in our center. Detailed information of baseline characteristics, periprocedural and long-term outcomes, and follow-up imaging was collected.</p><p><strong>Results: </strong>During 2012-2021, a total of 301 patients underwent CAS. Of which, CB-PTA was performed on 20 lesions exhibiting severe ISR in 18 patients following CAS. No patient had any history of receiving carotid endarterectomy or radiation therapy. These lesions were located at the cervical segment of the internal carotid artery (n=16), proximal external carotid artery (n=1), and distal common carotid artery (n=1). The median time interval between initial CAS and detection of ISR was 390 days (interquartile range 324-666 days). The follow-up period ranged from 9 months to 9 years with a median value of 21 months. Four patients (22.2%) were symptomatic. The average of stenotic degree before and after the procedure was 79.2% and 34.7%, respectively. Out of the 18 patients receiving CB-PTA, 16 (88.9%) did not require additional stenting, and 16 (88.9%) did not experience recurrent ISR during the follow-up period. Two patients who experienced recurrent ISR were successfully treated with CB-PTA and additional stenting. No periprocedural complication was observed in any case.</p><p><strong>Conclusion: </strong>Regarding favorable periprocedural and long-term outcomes in our single-center experience, CB-PTA was a feasible and safe option for the treatment of severe ISR after CAS.</p>\",\"PeriodicalId\":19140,\"journal\":{\"name\":\"Neurointervention\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10910177/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neurointervention\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5469/neuroint.2024.00010\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/2/8 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurointervention","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5469/neuroint.2024.00010","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/8 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:切割球囊经皮腔内血管成形术(CB-PTA)是颈动脉支架置入术(CAS)后支架内再狭窄(ISR)的一种可行治疗方案。然而,CB-PTA 治疗 CAS 后 ISR 的长期持久性和安全性尚未得到很好的证实:我们回顾性研究了本中心 2012 年至 2021 年期间接受 CB-PTA 治疗的 CAS 后 ISR 患者的病历。收集了基线特征、围术期和远期疗效以及随访影像学的详细信息:结果:2012-2021年间,共有301名患者接受了CAS手术。结果:2012-2021年间,共有301名患者接受了CAS手术,其中18名患者的20处病变表现出严重的ISR,接受了CB-PTA手术。没有患者接受过颈动脉内膜切除术或放射治疗。这些病变分别位于颈内动脉颈段(16 例)、颈外动脉近端(1 例)和颈总动脉远端(1 例)。初次 CAS 与发现 ISR 之间的中位时间间隔为 390 天(四分位间范围为 324-666 天)。随访时间从9个月到9年不等,中位值为21个月。有四名患者(22.2%)出现症状。手术前后的平均狭窄程度分别为 79.2% 和 34.7%。在接受 CB-PTA 的 18 位患者中,16 位(88.9%)不需要再进行支架植入,16 位(88.9%)在随访期间没有再出现 ISR。两名出现 ISR 复发的患者成功接受了 CB-PTA 和额外的支架治疗。所有病例均未出现围手术期并发症:结论:在我们的单中心经验中,CB-PTA 是治疗 CAS 后严重 ISR 的一种可行且安全的方法,其围手术期和远期疗效良好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Cutting Balloon Angioplasty for Severe In-Stent Restenosis after Carotid Artery Stenting: Long-Term Outcomes and Review of Literature.

Purpose: Cutting balloon-percutaneous transluminal angioplasty (CB-PTA) is a feasible treatment option for in-stent restenosis (ISR) after carotid artery stenting (CAS). However, the longterm durability and safety of CB-PTA for ISR after CAS have not been well established.

Materials and methods: We retrospectively reviewed medical records of patients with ISR after CAS who had been treated with CB-PTA from 2012 to 2021 in our center. Detailed information of baseline characteristics, periprocedural and long-term outcomes, and follow-up imaging was collected.

Results: During 2012-2021, a total of 301 patients underwent CAS. Of which, CB-PTA was performed on 20 lesions exhibiting severe ISR in 18 patients following CAS. No patient had any history of receiving carotid endarterectomy or radiation therapy. These lesions were located at the cervical segment of the internal carotid artery (n=16), proximal external carotid artery (n=1), and distal common carotid artery (n=1). The median time interval between initial CAS and detection of ISR was 390 days (interquartile range 324-666 days). The follow-up period ranged from 9 months to 9 years with a median value of 21 months. Four patients (22.2%) were symptomatic. The average of stenotic degree before and after the procedure was 79.2% and 34.7%, respectively. Out of the 18 patients receiving CB-PTA, 16 (88.9%) did not require additional stenting, and 16 (88.9%) did not experience recurrent ISR during the follow-up period. Two patients who experienced recurrent ISR were successfully treated with CB-PTA and additional stenting. No periprocedural complication was observed in any case.

Conclusion: Regarding favorable periprocedural and long-term outcomes in our single-center experience, CB-PTA was a feasible and safe option for the treatment of severe ISR after CAS.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.80
自引率
0.00%
发文量
34
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信